Workflow
Earnings estimate revision
icon
Search documents
PTC Inc. (PTC) Soars 17.7%: Is Further Upside Left in the Stock?
ZACKS· 2025-07-10 13:50
Core Viewpoint - PTC Inc. has experienced a significant increase in share price due to potential buyout interest from Autodesk, alongside strong financial forecasts and growth in product offerings [2][3]. Financial Performance - PTC shares ended the last trading session 17.6% higher at $210.47, with a notable trading volume [1] - The company has increased its free cash flow forecast for fiscal 2025 to $840-$850 million, reflecting a growth of 14-16% from the previous estimate [3] - Revenues for fiscal 2025 are projected to be between $2,445 million and $2,565 million, indicating a year-over-year rise of 6-12% [3] - Non-GAAP EPS is now estimated in the range of $5.80-$6.55, suggesting a rise of 14-29% [3] - The upcoming quarterly earnings are expected to be $1.22 per share, representing a year-over-year change of +24.5%, with revenues expected at $582.38 million, up 12.3% from the previous year [4] Market Position and Strategy - PTC is focused on mission-critical products and emphasizes verticalized go-to-market strategies to meet customer needs effectively [3] - The company is expanding its product portfolio to capture new customers in emerging IoT and AR/VR markets, with plans to integrate generative AI into its offerings [4] Industry Context - PTC Inc. belongs to the Zacks Computer - Software industry, which includes other companies like Simulations Plus [6] - Simulations Plus has seen a significant change in its EPS estimate, reflecting broader trends within the software industry [7]
Conagra Brands (CAG) Q4 Earnings and Revenues Miss Estimates
ZACKS· 2025-07-10 13:40
Conagra Brands (CAG) came out with quarterly earnings of $0.56 per share, missing the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.61 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -5.08%. A quarter ago, it was expected that this company would post earnings of $0.52 per share when it actually produced earnings of $0.51, delivering a surprise of -1.92%. Over the last four quarters, the company ...
Freightcar America (RAIL) Moves 18.6% Higher: Will This Strength Last?
ZACKS· 2025-07-10 10:16
Freightcar America (RAIL) shares rallied 18.6% in the last trading session to close at $11.66. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 20.2% gain over the past four weeks.The company has performed very well this year, with shares gaining 31% year to date. Strong demand for railcars and the company's efforts to reduce costs are boosting growth. RAIL has relocated production to a lower-cost region. The ...
CRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last?
ZACKS· 2025-07-10 09:26
Group 1: Stock Performance - CRISPR Therapeutics AG shares increased by 9.6% to close at $60.08, with notable trading volume compared to typical sessions [1] - The stock has gained 27.7% over the past four weeks, indicating strong investor interest [1] Group 2: Pipeline Developments - The rise in CRISPR's stock price is attributed to positive sentiment regarding its pipeline, particularly the in vivo candidate CTX310 targeting ANGPTL3 for atherosclerotic heart disease [2] - Updated data from an early-stage study showed a single dose of CTX310 resulted in peak reductions of up to 82% in triglyceride levels and up to 86% in LDL levels, generating excitement for other pipeline candidates [2] Group 3: Financial Expectations - The company is expected to report a quarterly loss of $1.54 per share, reflecting a year-over-year change of -3.4%, while revenues are projected at $5.89 million, a significant increase of 1032.9% from the previous year [3] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, suggesting that stock price movements may be influenced by trends in earnings estimate revisions [4] Group 4: Industry Context - CRISPR Therapeutics is part of the Zacks Medical - Biomedical and Genetics industry, where Wave Life Sciences also operates, closing the last trading session 10.8% higher at $7.7 [4] - Wave Life Sciences has seen a consensus EPS estimate change of -6.6% over the past month, indicating a potential decline in performance compared to the previous year [5]
Bassett Furniture (BSET) Surpasses Q2 Earnings and Revenue Estimates
ZACKS· 2025-07-09 23:45
Company Performance - Bassett Furniture (BSET) reported quarterly earnings of $0.22 per share, exceeding the Zacks Consensus Estimate of $0.15 per share, and compared to a loss of $0.19 per share a year ago, representing an earnings surprise of +46.67% [1] - The company posted revenues of $84.35 million for the quarter ended May 2025, surpassing the Zacks Consensus Estimate by 3.88%, and compared to year-ago revenues of $83.41 million [2] - Over the last four quarters, Bassett has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Outlook - Bassett shares have increased approximately 17.3% since the beginning of the year, outperforming the S&P 500's gain of 5.9% [3] - The current consensus EPS estimate for the coming quarter is $0.20 on $83.6 million in revenues, and for the current fiscal year, it is $0.88 on $334.66 million in revenues [7] - The estimate revisions trend for Bassett was favorable ahead of the earnings release, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Furniture industry, to which Bassett belongs, is currently in the top 37% of over 250 Zacks industries, suggesting a favorable outlook as the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8] - Another company in the same industry, Legget & Platt (LEG), is expected to report quarterly earnings of $0.29 per share, with revenues anticipated to be $1.06 billion, down 5.8% from the year-ago quarter [9]
BTCS Inc. (BTCS) Stock Jumps 111.1%: Will It Continue to Soar?
ZACKS· 2025-07-09 18:36
Company Overview - BTCS Inc. shares increased by 111.1% in the last trading session, closing at $5.91, with a significant volume of shares traded compared to normal sessions [1] - The stock had a 13.4% gain over the past four weeks, with a notable price rise following the announcement of a $100 million capital raise aimed at purchasing Ethereum [1] Business Strategy - BTCS focuses on Ethereum block-building through its Builder+ platform and validator node operations across various proof-of-stake (PoS) networks [2] - The company employs a non-custodial staking model to enhance trust and scalability, while its AI-powered ChainQ analytics platform improves data transparency [2] - Security is a priority, with 98% of crypto assets stored in encrypted cold storage, and proprietary infrastructure is used to optimize performance and efficiency [2] Financial Performance - The company is expected to report a quarterly loss of $0.07 per share, reflecting a year-over-year decline of 75% [3] - Revenue is projected to be $1.7 million, representing a 203.6% increase from the same quarter last year [3] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating that stock price movements may be influenced by trends in earnings estimate revisions [4] Industry Context - BTCS Inc. holds a Zacks Rank of 2 (Buy) within the Zacks Financial - Miscellaneous Services industry [5] - Another company in the same industry, Ponce Financial, closed the last trading session at $14.36, with a 1.4% increase, and has returned 6.6% over the past month [5] - Ponce Financial's consensus EPS estimate has remained unchanged at $0.17, showing a year-over-year change of +21.4% [6]
Post Holdings (POST) Upgraded to Buy: Here's Why
ZACKS· 2025-07-09 17:01
Investors might want to bet on Post Holdings (POST) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power of a ...
Qifu Technology, Inc. (QFIN) Upgraded to Strong Buy: Here's What You Should Know
ZACKS· 2025-07-09 17:00
Qifu Technology, Inc. (QFIN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the ...
All You Need to Know About AvePoint (AVPT) Rating Upgrade to Buy
ZACKS· 2025-07-09 17:00
Investors might want to bet on AvePoint, Inc. (AVPT) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power ...
All You Need to Know About Enhabit (EHAB) Rating Upgrade to Buy
ZACKS· 2025-07-09 17:00
Enhabit (EHAB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a changin ...